COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,226 Articles (22,733 medRxiv, 8,493 bioRxiv)

Most recent first Previous |  Page 1832: Articles 18311-18320  | Next

Diagnostic performance of standard and inverted grey-scale CXR in detection of lung lesions in COVID-19 patients. A single institution study in the region of Abu Dhabi.
Al Helali, A. A., Kukkady, M. A., Saeed, G. A., Elholiby, T. I., Al Mansoori, R. A., Ahmed, L. A.
10.1101/2021.02.01.21250914 — Posted: 2021-02-03
Impact of the COVID-19 Pandemic on anxiety and depression symptoms of young people in the Global South: evidence from a four-country cohort study
Porter, C., Favara, M., Hittmeyer, A., Scott, D., Sanchez Jimenez, A., Ellanki, R., Woldehanna, T., Duc, L. T., Craske, M. G., Stein, A.
10.1101/2021.02.02.21250897 — Posted: 2021-02-03
Association Between Preparedness and Response Measures and COVID-19 Incidence and Mortality
Lee, C. T., Buissonniere, M., McClelland, A., Frieden, T. R.
10.1101/2021.02.02.21251013 — Posted: 2021-02-03
Quantifying meaningful adoption of a SARS-CoV-2 exposure notification app on the campus of the University of Arizona
Masel, J., Shilen, A. N., Helming, B. H., Rutschman, J. D., Windham, G. D., Judd, M., Pogreba Brown, K., Ernst, K.
10.1101/2021.02.02.21251022 — Posted: 2021-02-03
First indication of the effect of COVID-19 vaccinations on the course of the COVID-19 outbreak in Israel
De-Leon, H., Calderon-Margalit, R., Pederiva, F., Ashkenazy, Y., Gazit, D.
10.1101/2021.02.02.21250630 — Posted: 2021-02-03
A cautionary note on recall vaccination in ex-COVID-19 subjects
Levi, R., Azzolini, E., Pozzi, C., Ubaldi, L., Lagioia, M., Mantovani, A., Rescigno, M.
10.1101/2021.02.01.21250923 — Posted: 2021-02-03 Discussion: Onsite
The role of the SwissCovid digital contact tracing app during the pandemic response: results for the Canton of Zurich
Menges, D., Aschmann, H. E., Moser, A., Althaus, C. L., von Wyl, V.
10.1101/2021.02.01.21250972 — Posted: 2021-02-03
Effect of co-infection with parasites on severity of COVID-19
Gebrecherkos, T., Gessesse, Z., Kebede, Y., Gebreegzabher, A., Tassew, G., Abdulkader, M., Ebuy, H., Desta, A., Hailu, A., Harris, V., Rinke de Wit, T., Wolday, D.
10.1101/2021.02.02.21250995 — Posted: 2021-02-03
Extremely high SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK
Gaskell, K. M., Johnson, M., Gould, V., Hunt, A., Stone, N. R., Waites, W., Kasstan, B., Chantler, T., Lal, S., Roberts, C. h., Goldblatt, D., Eggo, R. M., Marks, M. M.
10.1101/2021.02.01.21250839 — Posted: 2021-02-03
Rapid vaccination and early reactive partial lockdown will minimize deaths from emerging highly contagious SARS-CoV-2 variants
Reeves, D. B., Bracis, C., Swan, D. A., Moore, M., Dimitrov, D., Schiffer, J. T.
10.1101/2021.02.02.21250985 — Posted: 2021-02-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).